Abyrx acquisition of the HEMASORB Resorbable Hemostatic Bone Putty portfolio and the right to develop Bezwada Biomedical’s polymer technology for bone applications. The Company develops, manufactures, and provides therapeutic devices for use during surgical procedures.
Company growth
Type
Private
HQ
Irvington, US
Founded
2013
Size (employees)
11 (est)+10%
Abyrx was founded in 2013 and is headquartered in Irvington, US

Abyrx Office Locations

Abyrx has office in Irvington
Irvington, US

Abyrx Metrics

Abyrx Summary

Founding Date

2013

Total Funding

$10 M

Latest funding size

$10 M

Time since last funding

3 months

Investors

We estimate that Abyrx's latest funding round in December 2016 was $10 M. In total, Abyrx has raised $10 M

Abyrx Online Presence

Abyrx Company Life

You may also be interested in